Blb&B Advisors, LLC Astrazeneca PLC Transaction History

Blb&B Advisors, LLC

$1.93 Billion
Q4 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$55.72 - $67.12 $321,783 - $387,618	-5,775 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$54.02 - $63.83 $377,167 - $445,661	-6,982 Reduced 54.73%	5,775 $336,000
Q3 2021 Oct 19, 2021	SELL	$55.56 - $60.79 $228,740 - $250,272	-4,117 Reduced 24.4%	12,757 $766,000
Q2 2021 Jul 20, 2021	SELL	$48.42 - $60.18 $605,250 - $752,250	-12,500 Reduced 42.55%	16,874 $1.01 Million
Q1 2021 Apr 19, 2021	SELL	$47.16 - $54.44 $3.18 Million - $3.67 Million	-67,453 Reduced 69.66%	29,374 $1.46 Million
Q4 2020 Jan 19, 2021	BUY	$48.52 - $58.02 $332,750 - $397,901	6,858 Added 7.62%	96,827 $4.84 Million
Q3 2020 Oct 20, 2020	BUY	$53.07 - $61.1 $29,878 - $34,399	563 Added 0.63%	89,969 $4.93 Million
Q2 2020 Jul 16, 2020	SELL	$43.1 - $55.31 $276,357 - $354,647	-6,412 Reduced 6.69%	89,406 $4.73 Million
Q1 2020 Apr 21, 2020	SELL	$37.79 - $51.33 $57,478 - $78,072	-1,521 Reduced 1.56%	95,818 $4.28 Million
Q4 2019 Jan 21, 2020	SELL	$42.46 - $50.46 $73,455 - $87,295	-1,730 Reduced 1.75%	97,339 $4.85 Million
Q3 2019 Oct 22, 2019	SELL	$40.12 - $45.47 $281,441 - $318,972	-7,015 Reduced 6.61%	99,069 $4.42 Million
Q2 2019 Jul 29, 2019	SELL	$37.28 - $41.68 $55,920 - $62,520	-1,500 Reduced 1.39%	106,084 $4.38 Million
Q1 2019 Apr 19, 2019	BUY	$35.49 - $43.02 $513,753 - $622,757	14,476 Added 15.55%	107,584 $4.35 Million
Q4 2018 Jan 17, 2019	BUY	$36.86 - $41.49 $142,353 - $160,234	3,862 Added 4.33%	93,108 $3.54 Million
Q3 2018 Oct 12, 2018	BUY	$34.76 - $39.72 $673,509 - $769,614	19,376 Added 27.73%	89,246 $3.53 Million
Q2 2018 Jul 11, 2018	BUY	$34.55 - $37.05 $350,993 - $376,390	10,159 Added 17.01%	69,870 $2.45 Million
Q1 2018 Apr 09, 2018	BUY	$32.97 - $36.63 $160,300 - $178,095	4,862 Added 8.86%	59,711 $2.09 Million
Q4 2017 Jan 16, 2018	BUY	$32.09 - $34.78 $1.01 Million - $1.09 Million	31,388 Added 133.79%	54,849 $1.9 Million
Q3 2017 Oct 16, 2017	BUY	$28.96 - $34.0 $679,430 - $797,674	23,461	23,461 $795,000

Others Institutions Holding AZN

# of Institutions

1,356

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

Price T Rowe Associates Inc Baltimore, MD

60.4M
Shares

$4.48 Billion
0.46% of portfolio
Primecap Management CO Pasadena, CA

41M
Shares

$3.04 Billion
2.12% of portfolio
Capital International Investors Los Angeles, CA

37.5M
Shares

$2.78 Billion
0.48% of portfolio
Wellington Management Group LLP Boston, MA

37M
Shares

$2.75 Billion
0.46% of portfolio
Bank Of America Corp Charlotte, NC

24M
Shares

$1.78 Billion
0.13% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $230B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.

Account